Molecular Insight Pharmaceuticals realigns to cut costs

01/7/2010 | MarketWire

Molecular Insight Pharmaceuticals, a developer of targeted drugs and imaging radiopharmaceuticals, has announced its plan to eliminate nine positions in order to cut costs and further support its oncology pipeline. The company expects to save about $1 million annually as a result of the move.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC